GSK163929
Product Specifications
UNSPSC Description
GSK163929 (compound 122) is an orally active, anti-HIV CCR5 antagonist with low inhibitory potency against hEGR. GSK163929 had no adverse effects in rats at 2000 mg/kg/day (i.v., 7 d) and in dogs at 250 mg/kg/day (i.v., 7 d)[1].
Target Antigen
CCR; HIV
Type
Reference compound
Related Pathways
Anti-infection;GPCR/G Protein;Immunology/Inflammation
Field of Research
infection
Assay Protocol
https://www.medchemexpress.com/gsk163929.html
Smiles
CC1=NC2=C(C=CC=C2)N1C3C[C@H](CC4)N([C@H]4C3)CCC5(C6=CC(F)=CC=C6)CCN(C(C7=CC(S(=O)(NC)=O)=C(F)C=C7Cl)=O)CC5
Molecular Weight
696.25
References & Citations
[1]Kazmierski WM, et al. Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile. J Med Chem. 2011 Jun 9;54(11):3756-67.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-12944/GSK163929-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-12944/
Clinical Information
No Development Reported
CAS Number
716354-04-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
